Circ_0003489 facilitates multiple myeloma progression by targeting miR-433-3p/PBX3 axis

被引:9
|
作者
Yan, Tielun [1 ]
Wang, Xiaoli [2 ]
Zhou, Dajin [1 ]
Qiu, Haibo [3 ]
Zhang, Jiliang [3 ]
Yang, Weixiong [2 ]
机构
[1] Lishui Second Peoples Hosp, Dept Clin Lab, Lishui, Peoples R China
[2] Lishui Peoples Hosp, Dept Hematol, Lishui, Peoples R China
[3] Lishui Peoples Hosp, Clin Lab Ctr, Lishui, Peoples R China
关键词
Circ_0003489; miR-433-3p; PBX3; multiple myeloma; CELL; PROLIFERATION; CARCINOMA; CANCER;
D O I
10.1080/16078454.2022.2109554
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Multiple myeloma (MM) is a relatively common hematologic tumor, and the study of non-coding RNAs in MM is gradually increasing. Our study aimed to reveal the regulatory mechanism of circular RNA_0003489 (circ_0003489)/microRNA-433-3p (miR-433-3p)/Pre-B-cell leukemia homeobox 3 (PBX3) axis in MM. Methods: Circ_0003489, miR-433-3p and PBX3 contents were measured by real-time quantitative PCR or western blot. Functionally, MM cell proliferation and apoptosis were evaluated using cell counting kit-8, flow cytometry and EdU assays. Interaction between miR-433-3p and circ_0003489 or PBX3 was confirmed with the application of dual-luciferase reporter assay and RNA pull down assay. Results: Circ_0003489 and PBX3 were upregulated, while miR-433-3p was downregulated in MM tissues. Circ_0003489 knockdown or miR-433-3p overexpression remarkably suppressed MM proliferation and increased apoptosis in vitro. In terms of mechanism, circ_0003489 could sponge miR-433-3p to regulate PBX3. Besides, miR-433-3p downregulation or PBX3 overexpression reversed the inhibition effect of circ_0003489 knockdown on MM progression. Conclusion: Circ_0003489 facilitated MM progression by targeting miR-433-3p/PBX3 axis, suggesting that it might be a potential target for MM.
引用
收藏
页码:951 / 959
页数:9
相关论文
共 50 条
  • [1] LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis
    Xiao, Shangwen
    Song, Bin
    BIOSCIENCE REPORTS, 2020, 40
  • [2] miR-433-3p Targets AJUBA to Inhibit Malignant Progression of Glioma
    Zhang, Jing
    Guo, Yihang
    Ma, Yanrong
    Wang, Lipeng
    Li, Weiyuan
    Zhang, Manyu
    Zhao, Jiaming
    Hu, Yueming
    Yu, Hongmei
    Hu, Guozhi
    NEUROIMMUNOMODULATION, 2022, 29 (01) : 44 - 54
  • [3] LncRNA LINC00885 promotes bladder cancer progression by targeting the miR-98-5p/ PBX3 axis
    Xia, Zongyu
    Wang, Qin
    Lu, Peng
    CELLULAR AND MOLECULAR BIOLOGY, 2023, 69 (03) : 163 - 168
  • [4] Long noncoding RNA SNHG14 promotes osteosarcoma progression via miR-433-3p/FBXO22 axis
    Hou, Xun-Kai
    Mao, Jun-Sheng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 523 (03) : 766 - 772
  • [5] Knockdown of circ_0008344 contributes to radiosensitization in glioma via miR-433-3p/RNF2 axis
    Di, Liang
    Zhao, Xiaofei
    Ding, Jing
    JOURNAL OF BIOSCIENCES, 2021, 46 (03)
  • [6] Novel insights into the circ_0003489/let-7b-5p/GLUT1 axis and its possible role in multiple myeloma
    Wang, Xiaoyan
    Yang, Qinqin
    Wu, Yuedi
    TRANSPLANT IMMUNOLOGY, 2025, 88
  • [7] MiR-433-3p suppresses cell growth and enhances chemosensitivity by targeting CREB in human glioma
    Sun, Shupeng
    Wang, Xiuyu
    Xu, Xinnv
    Di, Hui
    Du, Jixiang
    Xu, Bin
    Wang, Qiong
    Wang, Jinhuan
    ONCOTARGET, 2017, 8 (03) : 5057 - 5068
  • [8] MicroRNA-144-3p suppresses gastric cancer progression by inhibiting epithelial-to-mesenchymal transition through targeting PBX3
    Li, Butian
    Zhang, Shengping
    Shen, Hao
    Li, Chenglong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 484 (02) : 241 - 247
  • [9] Long Noncoding RNA PCGEM1 Facilitates Tumor Growth and Metastasis of Osteosarcoma by Sponging miR-433-3p and Targeting OMA1
    Li, Jun
    Zhang, Yuanjin
    Sun, Farui
    Zhang, Guofu
    Pan, Xi-an
    Zhou, Qian
    ORTHOPAEDIC SURGERY, 2023, 15 (04) : 1060 - 1071
  • [10] Circular RNA circLGMN facilitates glioblastoma progression by targeting miR-127-3p/LGMN axis
    Chen, Binghong
    Wang, Mengying
    Huang, Renhua
    Liao, Keman
    Wang, Tianwei
    Yang, Renhao
    Zhang, Wenrui
    Shi, Zhonggang
    Ren, Li
    Lv, Qi
    Ma, Chunhui
    Lin, Yingying
    Qiu, Yongming
    CANCER LETTERS, 2021, 522 : 225 - 237